AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 281: H359-H370, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itoh, H.
Right arrow Articles by Kent, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, H.
Right arrow Articles by Kent, K. C.
Vol. 281, Issue 1, H359-H370, July 2001

Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration

Hiroyuki Itoh1, Shinji Yamamura1, J. Anthony Ware2, Shaobin Zhuang1, Shinsuke Mii1, Bo Liu1, and K. Craig Kent1

1 Division of Vascular Surgery, New York Hospital and Cornell University Medical Center, New York 10021; and 2 Cardiovascular Division, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, New York 10461

Vascular smooth muscle cell (SMC) migration and proliferation contribute to intimal hyperplasia, and protein kinase C (PKC) may be required for both events. In this report, we investigated the role of PKC in proliferation and migration of SMC derived from the human saphenous vein. Activation of PKC by phorbol-12,13-dibutyrate (PDBu) or (-)-indolactam [(-)-ILV] increases SMC proliferation. Downregulation of PKC activity by prolonged incubation with phorbol ester or inhibition of PKC with chelerythrine in SMC diminished agonist-stimulated proliferation. In contrast, stimulation of PKC with PDBu or (-)-ILV inhibited basal and agonist-induced SMC chemotaxis. Moreover, downregulation of PKC or inhibition with chelerythrine accentuated migration. We postulated that the inhibitory effect of PKC on SMC chemotaxis was mediated through cAMP-dependent protein kinase (protein kinase A, PKA). In support of this hypothesis, we found that activation of PKC in SMC stimulated PKA activity. The cAMP agonist forskolin significantly inhibited SMC chemotaxis. Furthermore, the inhibitory effect of PKC on SMC chemotaxis was completely reversed by cAMP or PKA inhibitors. In search of the PKC isotype(s) underlying these differential effects of PKC in SMC, we identified eight isotypes expressed in human SMC. Only PKC-alpha , -beta I, -delta , and -epsilon were eliminated by downregulation, suggesting that one or more of these four enzymes facilitate the observed phorbol ester-dependent effects of PKC in SMC. In summary, we found that PKC activation enhances proliferation but inhibits migration of human vascular SMC. These differential effect of PKC on vascular cells appears to be mediated through PKC-alpha , -beta I, -delta , and/or -epsilon .

isoenzymes; cAMP; cAMP-dependent protein kinase; signal transduction


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
D. Yamanouchi, K. Kato, E. J. Ryer, F. Zhang, and B. Liu
Protein kinase C delta mediates arterial injury responses through regulation of vascular smooth muscle cell apoptosis
Cardiovasc Res, October 31, 2009; (2009) cvp328v2.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. S. Monahan, N. D. Andersen, M. C. Martin, J. Y. Malek, G. V. Shrikhande, L. Pradhan, C. Ferran, and F. W. LoGerfo
MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein
FASEB J, February 1, 2009; 23(2): 557 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Schroder, I. Helmcke, K. Palfi, K.-H. Krause, R. Busse, and R. P. Brandes
Nox1 Mediates Basic Fibroblast Growth Factor-Induced Migration of Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1736 - 1743.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. Milan, C. Charalambous, R. Elhag, T. C. Chen, W. Li, S. Guan, F. M. Hofman, and R. Zidovetzki
Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration
Am J Physiol Cell Physiol, July 1, 2006; 291(1): C155 - C164.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. A. Goncharova, C. K. Billington, C. Irani, A. V. Vorotnikov, V. A. Tkachuk, R. B. Penn, V. P. Krymskaya, and R. A. Panettieri Jr.
Cyclic AMP-Mobilizing Agents and Glucocorticoids Modulate Human Smooth Muscle Cell Migration
Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 19 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. Ito, E. Kusano, Y. Furukawa, H. Yamamoto, S.-I. Takeda, T. Akimoto, O. Iimura, Y. Ando, and Y. Asano
Modulation of the erythropoietin-induced proliferative pathway by cAMP in vascular smooth muscle cells
Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1715 - C1721.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Sun, X. Sui, J. A. Bradbury, D. C. Zeldin, M. S. Conte, and J. K. Liao
Inhibition of Vascular Smooth Muscle Cell Migration by Cytochrome P450 Epoxygenase-Derived Eicosanoids
Circ. Res., May 17, 2002; 90(9): 1020 - 1027.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online